FDA Logo U.S. Food and Drug AdministrationCenter for Food Safety and Applied Nutrition
 U.S. Department of Health and Human Services

FDA Home Page | CFSAN Home | Search/Subject Index | Q & A | Help

horizontal rule

July 2007

horizontal rule

2007 Cardiovascular Biomarkers and Surrogate Endpoints Symposium

ASSESSING CARDIOVASCULAR RISK AND PROGRESSION

October 17-19, 2007
Bethesda North Marriott
Hotel & Conference Center
Bethesda, Maryland

Registration Deadline: October 15, 2007

Program and Registration

Registration, agenda, and additional information is available in PDF (252 KB).

CO-CHAIRS

Peter Libby, M.D.
Mallinckrodt Professor of Medicine
Harvard Medical School and
Chief Cardiovascular Medicine
Brigham and Women's Hospital

Jean-Claude Tardif, M.D.
Director, Research Center
Professor of Medicine
CIHR Chair in Atherosclerosis
Montreal Heart Institute

The objectives of this program are to:

  • Provide the latest information on cardiovascular imaging technology, in-vitro biomarkers, and the use of genomics, proteomics, and metabolomics
  • Identify challenges in the development, validation, and application of cardiovascular biomarkers and seek strategies to improve successful outcome
  • Create efficiencies toward improved patient healthcare

This meeting is co-sponsored by:

BWH - Brigham and Women's Hospital, A teaching affiliate of Harvard Medical School NHLBI - National Heart Lung and Blood Institute, People Science Health
MHICC - Montreal Heart Institute Coordinating Center
U.S. Department of Health and Human Services
U.S. Food and Drug Administration
Center for Food Safety and Applied Nutrition
MHICC - Montreal Heart Institute Coordinating Center
horizontal rule
Food Labeling and Nutrition   |   Public Meetings
horizontal rule
CFSAN Home | CFSAN Search/Subject Index | CFSAN Disclaimers & Privacy Policy | CFSAN Accessibility/Help
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Center for Food Safety & Applied Nutrition
Hypertext updated by dms July 20, 2007